KATY, TX / ACCESS Newswire / April 30, 2026 / A groundbreaking study published in the prestigious journal Cell Metabolism ...
The Brighterside of News on MSN
Study finds low-dose CAR T therapy can drive complete cancer remission
A bone marrow transplant can buy time for people with aggressive B-cell cancers. Too often, it does not buy enough. For ...
Researchers have validated an AI-assisted flow cytometry system that can analyze complex immunological data in under five minutes per case, matching expert accuracy. The DeepFlow™ platform ...
CAR T-cell therapy has transformed the treatment of hematologic malignancies, yet many patients do not achieve lasting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results